Is Iovance Biotherapeutics a Millionaire-Maker?

Some investors see a striking similarity between lottery tickets and biotech stocks. In most cases, buying lottery tickets ends up being a waste of money. So does investing in most biotech stocks. But just as one lucky lottery ticket can provide game-changing wealth, so can the right biotech stock.Iovance Biotherapeutics (NASDAQ: IOVA) just might be the right kind of biotech stock. The company has already achieved success. Could it even be a millionaire-maker?To appreciate Iovance's opportunity, we need to first gain a basic understanding of the company's primary scientific focus. Iovance is a leader in developing tumor-infiltrating lymphocyte (TIL) therapies. TILs are immune cells that attack tumor cells. Their big challenge, though, is that they often can't recognize the cancerous cells as an enemy and are rendered ineffective.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool